Treatment of unresectable esophageal carcinoma by stenting with or without radiochemotherapy / 中华肿瘤杂志
Chinese Journal of Oncology
;
(12): 109-111, 2004.
Article
in Chinese
| WPRIM
| ID: wpr-271055
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the benefits of post-stenting radiotherapy and/or chemotherapy for unresectable esophageal carcinoma.</p><p><b>METHODS</b>Fifty-three patients with unresectable esophageal carcinoma were randomly divided into two groups patients in group A (n = 27) were treated with stenting alone, and those in group B (n = 26) were treated with stenting followed by radiotherapy and/or chemotherapy. Comparison was made by assessing their survival time, quality of life (QOL), degree of dysphagia, and stenting-related morbidity, respectively.</p><p><b>RESULTS</b>There was no statistically significant improvement in dysphagia and QOL between the two groups. Although there was no difference in the frequency of stenting-related complications, re-stenosis occurred much less frequently in group B patients (P = 0.007). The mean survival time of patients was 245 +/- 41 days and 262 +/- 43 days in group A and group B, respectively. There was no significant difference between the two groups (P = 0.813).</p><p><b>CONCLUSION</b>Besides decreased recurrence of stenosis, post-stenting radiotherapy and/or chemotherapy does not provide additional benefits for survival.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Therapeutics
/
Esophageal Neoplasms
/
Stents
/
Mortality
/
Combined Modality Therapy
Type of study:
Prognostic study
Limits:
Female
/
Humans
/
Male
Language:
Chinese
Journal:
Chinese Journal of Oncology
Year:
2004
Type:
Article
Similar
MEDLINE
...
LILACS
LIS